COVID–19 Emergency Medical Supplies Enhancement Act of 2021
COVID-19 Emergency Medical Supplies Enhancement Act of 2021 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) and authorizes the President and federal agencies to take specific actions to support the production of critical medical supplies during the COVID-19 (i.e., coronavirus disease 2019) emergency, including with respect to private-sector coordination, needs assessments, and overall strategies. The bill makes loans under the DPA subject to certain notification requirements. A report required under the DPA for FY2022 and FY2023 shall include the percentage of contracts awarded to small businesses.
Public-private cooperation
Health promotion and preventive care
Public contracts and procurement
Medical tests and diagnostic methods
Infectious and parasitic diseases
Government Operations and Politics
Cardiovascular and respiratory health
Administrative law and regulatory procedures
Small business
Congressional oversight
Manufacturing
Health technology, devices, supplies
Government lending and loan guarantees
Strategic materials and reserves
Emergency medical services and trauma care
Worker safety and health
Drug therapy
Military procurement, research, weapons development
← Back to Juan Vargas's profile